The Megadeal Mood Swing: Why 2026's M&A Boom Is Equity-Led Strategic Urgency, Not Leverage Euphoria Redux

John Grey — Macro and cross-asset desk

Morgan Stanley's July 9 note to clients projected global mergers-and-acquisitions volumes will reach $6.4 trillion in 2026, topping the 2021 record of $6.1 trillion by roughly $500 billion and marking the highest annual total ever recorded. Goldman Sachs's 2H 2026 Global M&A Outlook, published July 22 by Global Head of M&A Stephan Feldgoise, put first-half 2026 volumes up 48 percent year-on-year, with mega-deal volumes up 125 percent. JPMorgan Chase reported Q2 investment banking fees up 30 percent to the highest level since 2021. The six largest U.S. banks collectively posted investment banking fee growth of 45 percent, with Morgan Stanley leading. Announced global M&A volume has passed $3 trillion for 2026 year-to-date per Dealogic. This is the deal cycle's actual moment of arrival. The consensus reading has been immediate, and largely wrong: this is being described in the market as the 2021 leverage euphoria returning. It is not. The specific composition of the deals being announced, the survey data on why boards are moving now, and the funding stack behind the largest transactions describe a different cycle. This is equity-issuance-led strategic urgency at record valuations, not private-equity leverage-driven speculation at low rates. That distinction is not semantic. It changes the correct positioning across the deal-related equity and credit complex.

Consider the specific transactions defining the cycle. Alphabet raised $85 billion in equity in Q2 2026, the largest single equity offering in the market's history, with JPMorgan as lead active bookrunner. SpaceX conducted an $85.7 billion IPO in the same quarter, the largest listing on record. NextEra Energy's announced $118.8 billion merger with Dominion Energy — proposed at $67 billion when it was initially reported and later disclosed at the higher enterprise value in the Goldman outlook — is a stock-and-cash strategic combination in regulated utilities. Unilever Foods's $44.8 billion merger with McCormick is scrip-heavy consumer-staples consolidation. Merck KGaA's $11.3 billion purchase of Bio-Techne is a healthcare tools acquisition funded through a balanced cash-and-debt structure with no LBO leverage. Honeywell's approximately $88 billion aerospace separation and the KONE-TKE merger valued at EUR 29.4 billion are both structural corporate-portfolio actions. Every single one of these transactions is either an equity-led combination, a corporate restructuring, or a fundamentally different structural transaction from the mega-LBOs that defined 2021. Private equity is participating in the volume but not driving the character of the megadeal set.

Feldgoise framed the shift in his July 22 note. In his exact words, published on the Goldman Sachs Investment Banking site under his own name:

"We're seeing a fundamental shift where boardrooms view inaction as the ultimate risk — proactively pursuing transformative transactions despite persistent macroeconomic headwinds."

Feldgoise's phrase "inaction as the ultimate risk" is the specific behavioral marker. This is a boardroom cycle, not a sponsor cycle. Goldman's survey of more than 500 corporate and financial-sponsor clients, conducted in June 2026, found nearly 60 percent of respondents cited scale and strategic growth as their primary M&A driver, with fewer than half characterizing current conditions as suitable for opportunistic buyouts. That is a fundamentally different response distribution from the 2021 survey era, when private-equity respondents dominated and financial engineering was cited as the primary driver by more than half of sponsors. The 2026 cycle is being pushed by CEOs and boards responding to AI, geopolitical fragmentation, and regulatory recalibration by consolidating rather than by sponsors responding to cheap financing by levering up.

Tom Miles, global co-head of M&A at Morgan Stanley, gave the working framing to Bloomberg on July 1:

"People have just accepted the volatility and are investing through it as opposed to waiting until it's over," Miles told Bloomberg for the outlet's first-half M&A wrap-up.

Miles's point is the demand-side complement to Feldgoise's supply-side observation. Boards have concluded that the specific volatility environment — Federal Reserve uncertainty under Kevin Warsh's no-guidance regime, Middle East disruption, Ukraine-Russia continuing, US-China trade friction — is the new baseline and cannot be waited out. Waiting to transact until the world becomes calmer is now understood as waiting indefinitely. That psychological pivot from "wait for clarity" to "act into uncertainty" is what has produced the volume. It is also what makes this cycle less rate-sensitive than the 2021 comparison implies. If deals are being done on strategic urgency rather than leverage arbitrage, a Federal Reserve hike into deteriorating inflation dynamics does not automatically stall the pipeline in the way it would if leverage arbitrage were driving the cycle.

The financing composition is the real tell

What separates 2026 from 2021 most cleanly is the funding stack. In 2021, the median mega-deal used 60 to 70 percent debt in its financing composition, with senior secured loans and high-yield bonds absorbing the load. Private-equity buyout leverage ratios routinely reached 6-to-7 times EBITDA. In 2026, based on the composition of transactions disclosed to date, the median mega-deal is majority equity-financed. The Alphabet $85 billion raise and the SpaceX $85.7 billion IPO are pure equity events. NextEra's combination with Dominion is largely stock. Unilever Foods's merger with McCormick is largely scrip. This is not a coincidence. Global equity valuations are at levels that make stock-financed deals accretive for the acquirer even when purchase premiums are large. The S&P 500 forward earnings multiple is around 22 times against a ten-year median of 18. That valuation environment specifically favors equity-issuance-led deal-making and specifically disfavors leveraged buyouts, which need cash flow to service debt.

Jamie Dimon, JPMorgan CEO, sat directly with this reality on the Q2 earnings call on July 14, in his exact words:

"We're in a very healthy, active, exuberant market with very high prices and very high volumes, and we benefit from that. We just don't know how long it will continue."

Dimon's construction is telling on two dimensions. First, he identifies "very high prices" as a cycle feature, which is compatible with equity-led deal-making but not with leverage-led deal-making at these rates. Second, he refuses to characterize the cycle's duration, which is the position an experienced bank CEO takes when the drivers are not the traditional debt cycle. His CFO Jeremy Barnum, on the same call, characterized the pipeline in JPMorgan's exact phrasing: "The pipeline remains quite robust, and the current activity levels seem to be encouraging more activity." That is a description of positive feedback dynamics in strategic deal-making rather than of a debt-market technical driving volume.

Where the consensus reading breaks

The market has extended the 2021 comparison to derive a specific expectation: that any Fed hike, any credit-market widening, or any equity-valuation retracement will end the cycle abruptly the way it ended in 2022. That derivation ignores what the actual funding stack is. A shift in credit-market conditions matters materially less when the transactions are equity-financed strategic combinations rather than leveraged buyouts. What matters more is the equity-valuation environment continuing to support acquirer accretion, and the boardroom perception that inaction risk remains higher than transaction risk. Both of those conditions are more sensitive to earnings-cycle dynamics than to rates. The correct predictor for the durability of this cycle is not the two-year yield. It is S&P 500 forward earnings growth expectations and, at a more granular level, the median CEO tenure expectation — the average sitting US large-cap CEO has been in the seat for 5.4 years, near the historical low, and the specific psychological driver Feldgoise identifies is a CEO cohort under intense pressure to demonstrate structural strategic action before their tenure expires.

David Wagner, head of equities and portfolio manager at Aptus Capital Advisors, gave Reuters the framing on July 15 that captures the market's implicit view:

"Investment banking divisions experienced their strongest fee-generating quarter since the peak of 2021," Wagner said. "The major investment banks comfortably cleared Wall Street's profit forecasts by wide margins, signaling one of the most bullish dealmaking environments the sector has seen in years."

Wagner reads this cleanly. The specific translation issue is that "strongest since 2021" is not "the same as 2021" for the equity-related trades. The banks' fee streams benefit from either leverage-led or equity-led cycles indifferently, so bank equities can validate both cycles. Deal-related equities — the acquirers, the targets, the arb spreads, the pending deal universe — behave differently in equity-led than in leverage-led cycles, and current positioning across those instruments assumes leverage-led dynamics.

Our view

The correct positioning has three components. First, long the acquirer basket rather than short it. In leverage-led cycles, acquirers underperform because leverage overhang overwhelms accretion. In equity-led cycles, acquirers outperform because the accretion is real and immediate. The current market treatment of large-cap acquirers, discounting them on 2021-style overhang assumptions, is mispriced. Second, tighten the deal-arb spread. Median announced-to-close spreads for equity-financed strategic deals are currently trading at 12 to 15 percent annualized, versus a normal cycle range of 6 to 10 percent for cash-financed deals. Regulatory environment under the Trump administration's more permissive stance, per Feldgoise's characterization of "a more benign regulatory regime," should compress those spreads by 3 to 4 percentage points on completion certainty alone. Third, long the private-markets exit trade. Goldman's outlook flags 16,000 GP-owned portfolio companies held for four-plus years, representing more than half of all buyout-backed inventory, with private markets holding roughly 30 percent of all software exposure. The exit backlog is the underappreciated multi-year tailwind for M&A volume, particularly software M&A. The specific expression is long large-cap software acquirers with strategic platform positioning against short PE-backed listed peers with concentrated backlog exposure.

The larger frame is about how boards respond to a specific type of macroeconomic environment. The 2021 cycle was a leverage cycle powered by zero rates and stimulus. The 2026 cycle is an urgency cycle powered by AI, geopolitical fragmentation, and CEO tenure pressure into equity valuations that finally justify major stock-financed action. That is a fundamentally different cycle. It rewards different positioning. It runs on different signals. The consensus is currently pricing it as the wrong cycle. That is the trade.

This note reflects the views of Solomon Grey Capital's Macro and cross-asset desk as of the date of publication and is provided for informational purposes only. It does not constitute investment advice, an offer, or a solicitation to buy or sell any security. Past performance is not indicative of future results.